Umbilical cord mesenchymal stem cell transplantation in …

Petri M: Systemic lupus erythematosus: 2006 update.

J Clin Rheumatol 2006, 12:37-40. PubMedAbstract | PublisherFullText

Hoffman RW: T cells in the pathogenesis of systemic lupus erythematosus.

Clin Immunol 2004, 113:4-13. PubMedAbstract | PublisherFullText

Sanz I: Connective tissue diseases: targeting B cells in SLE: good news at last!

Nat Rev Rheumatol 2011, 7:255-256. PubMedAbstract | PublisherFullText

Liu Z, Davidson A: Taming lupusa new understanding of pathogenesis is leading to clinical advances.

Nat Med 2012, 18:871-882. PubMedAbstract | PublisherFullText | PubMedCentralFullText

Rahman A, Isenberg DA: Systemic lupus erythematosus.

N Engl J Med 2008, 358:929-939. PubMedAbstract | PublisherFullText

Karim MY, Pisoni CN, Khamashta MA: Update on immunotherapy for systemic lupus erythematosuswhats hot and whats not.

Rheumatology (Oxford) 2009, 48:332-341. PubMedAbstract | PublisherFullText

Merrill JT, Ginzler EM, Wallace DJ, McKay JD, Lisse JR, Aranow C, Wellborne FR, Burnette M, Condemi J, Zhong ZJ, Pineda L, Klein J, Freimuth WW, LBSL02/99 Study Group: Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.

Arthritis Rheum 2012, 64:3364-3373. PubMedAbstract | PublisherFullText

Manzi S, Snchez-Guerrero J, Merrill JT, Furie R, Gladman D, Navarra SV, Ginzler EM, DCruz DP, Doria A, Cooper S, Zhong ZJ, Hough D, Freimuth W, Petri MA, BLISS-52 and BLISS-76 Study Groups: Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.

Ann Rheum Dis 2012, 71:1833-1838. PubMedAbstract | PublisherFullText | PubMedCentralFullText

Alexander T, Thiel A, Rosen O, Massenkeil G, Sattler A, Kohler S, Mei H, Radtke H, Gromnica-Ihle E, Burmester GR, Arnold R, Radbruch A, Hiepe F: Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system.

Blood 2009, 113:214-223. PubMedAbstract | PublisherFullText

Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues.

Science 1997, 276:71-74. PubMedAbstract | PublisherFullText

Loh Y, Oyama Y, Statkute L, Quigley K, Yaung K, Gonda E, Barr W, Jovanovic B, Craig R, Stefoski D, Cohen B, Burt RK: Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used.

Blood 2007, 109:2643-2648. PubMedAbstract | PublisherFullText

Conget PA, Minguell JJ: Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells.

J Cell Physiol 1999, 181:67-73. PubMedAbstract | PublisherFullText

Sanchez-Ramos J, Song S, Cardozo-Peleza F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR: Adult bone marrow stromal cells differentiate into neural cells in vitro.

Exp Neurol 2000, 164:247-256. PubMedAbstract | PublisherFullText

Saulnier N, Lattanzi W, Puglisi MA, Pani G, Barba M, Piscaglia AC, Giachelia M, Alfieri S, Neri G, Gasbarrini G, Gasbarrini A: Mesenchymal stromal cells multipotency and plasticity: induction toward the hepatic lineage.

Eur Rev Med Pharmacol Sci 2009, 13:71-78.

Fan L, Lin C, Zhuo S, Chen L, Liu N, Luo Y, Fang J, Huang Z, Lin Y, Chen J: Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction.

Eur J Heart Fail 2009, 11:1023-1030. PubMedAbstract | PublisherFullText

Keating A: Mesenchymal stromal cells: new directions.

Cell Stem Cell 2012, 10:709-716. PubMedAbstract | PublisherFullText

Le Blanc K, Mougiakakos D: Multipotent mesenchymal stromal cells and the innate immune system.

Nat Rev Immunol 2012, 12:383-396. PubMedAbstract | PublisherFullText

English K, French A, Wood KJ: Mesenchymal stromal cells: facilitators of successful transplantation?

Cell Stem Cell 2010, 7:431-442. PubMedAbstract | PublisherFullText

Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, Hua B, Liu B, Ye S, Hu X, Xu W, Zeng X, Hou Y, Gilkeson GS, Silver RM, Lu L, Shi S: Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus.

Arthritis Rheum 2010, 62:2467-2475. PubMedAbstract | PublisherFullText

Liang J, Zhang H, Hua B, Wang H, Lu L, Shi S, Hou Y, Zeng X, Gilkeson GS, Sun L: Allogeneic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study.

Ann Rheum Dis 2010, 69:1423-1429.

A published erratum appears in Ann Rheum Dis

Wang D, Zhang H, Liang J, Li X, Feng X, Wang H, Hua B, Liu B, Lu L, Gilkeson GS, Silver RM, Chen W, Shi S, Sun L: Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4years of experience.

Cell Transplant 2013, 22:2267-2277. PubMedAbstract | PublisherFullText

Boumpas DT, Austin HA 3rd, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE: Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

Lancet 1992, 340:741-745. PubMedAbstract | PublisherFullText

Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Steinberg AD, Klippel JH, Balow JE, Boumpas DT: Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

Ann Intern Med 2001, 135:248-257. PubMedAbstract | PublisherFullText

Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN, Hong KongGuangzhou Nephrology Study Group: Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.

N Engl J Med
2000, 343:1156-1162. PubMedAbstract | PublisherFullText

Weening JJ, DAgati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited.

J Am Soc Nephrol 2004, 15:241-250.

A published erratum appears in J Am Soc Nephrol 2004, 15:835836

Merrill JT, Neuwelt CM, Wallace DJ, Shanahan JC, Latinis KM, Oates JC, Utset TO, Gordon C, Isenberg DA, Hsieh HJ, Zhang D, Brunetta PG: Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.

Arthritis Rheum 2010, 62:222-233. PubMedAbstract | PublisherFullText

Symmons DP, Coppock JS, Bacon PA, Bresnihan B, Isenberg DA, Maddison P, McHugh N, Snaith ML, Zoma AS, British Isles Lupus Assessment Group (BILAG): Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus.

Q J Med 1988, 69:927-937. PubMedAbstract | PublisherFullText

Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, Symmons DP, Viner N, Zoma A: The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus.

Q J Med 1993, 86:447-458. PubMedAbstract | PublisherFullText

Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringdn O, Developmental Committee of the European Group for Blood and Marrow Transplantation: Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Lancet 2008, 371:1579-1586. PubMedAbstract | PublisherFullText

Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, Locatelli F, Fibbe WE: Cotransplantation of ex vivoexpanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation.

Blood 2007, 110:2764-2767. PubMedAbstract | PublisherFullText

Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW, George R, Lardo A: Comparison of allogeneic vs autologous bone marrowderived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

JAMA 2012, 308:2369-2379. PubMedAbstract | PublisherFullText

Song H, Song BW, Cha MJ, Choi IG, Hwang KC: Modification of mesenchymal stem cells for cardiac regeneration.

Expert Opin Biol Ther 2010, 10:309-319. PubMedAbstract | PublisherFullText

Akiyama K, Chen C, Wang D, Xu X, Qu C, Yamaza T, Cai T, Chen W, Sun L, Shi S: Mesenchymal stem cell-induced immunoregulation involves Fas-ligand/Fas-mediated T cell apoptosis.

Cell Stem Cell 2012, 10:544-555. PubMedAbstract | PublisherFullText | PubMedCentralFullText

Liang J, Zhang H, Wang D, Feng X, Wang H, Hua B, Liu B, Sun L: Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease.

Gut 2012, 61:468-469. PubMedAbstract | PublisherFullText

Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, Minelli A, Alvisi C, Vanoli A, Calliada F, Dionigi P, Perotti C, Locatelli F, Corazza GR: Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohns disease.

Gut 2011, 60:788-798. PubMedAbstract | PublisherFullText

Wang D, Zhang H, Cao M, Tang Y, Liang J, Feng X, Wang H, Hua B, Liu B, Sun L: Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis.

Ann Rheum Dis 2011, 70:1285-1288. PubMedAbstract | PublisherFullText

Liang J, Li X, Zhang H, Wang D, Feng X, Wang H, Hua B, Liu B, Sun L: Allogeneic mesenchymal stem cells transplantation in patients with refractory RA.

Clin Rheumatol 2012, 31:157-161. PubMedAbstract | PublisherFullText

Xu J, Wang D, Liu D, Fan Z, Zhang H, Liu O, Ding G, Gao R, Zhang C, Ding Y, Bromberg JS, Chen W, Sun L, Wang S: Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjgren syndrome.

Blood 2012, 120:3142-3151. PubMedAbstract | PublisherFullText | PubMedCentralFullText

Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yaez AJ, Conget PA: Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.

Biol Blood Marrow Transplant 2008, 14:631-640. PubMedAbstract | PublisherFullText

Jiang R, Han Z, Zhuo G, Qu X, Li X, Wang X, Shao Y, Yang S, Han ZC: Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study.

Front Med 2011, 5:94-100. PubMedAbstract | PublisherFullText

Wang D, Akiyama K, Zhang H, Yamaza T, Li X, Feng X, Wang H, Hua B, Liu B, Xu H, Chen W, Shi S, Sun L: Double allogeneic mesenchymal stem cells transplantations could not enhance therapeutic effect compared with single transplantation in systemic lupus erythematosus.

Clin Dev Immunol 2012, 2012:273291. PubMedAbstract | PublisherFullText | PubMedCentralFullText

Tang Y, Xie H, Chen J, Geng L, Chen H, Li X, Hou Y, Lu L, Shi S, Zeng X, Sun L: Activated NF-B in bone marrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating Smad signaling.

Stem Cells Dev 2013, 22:668-678. PubMedAbstract | PublisherFullText | PubMedCentralFullText

Li X, Liu L, Meng D, Wang D, Zhang J, Shi D, Liu H, Xu H, Lu L, Sun L: Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus.

Stem Cells Dev 2012, 21:2387-2394. PubMedAbstract | PublisherFullText

Kastrinaki MC, Sidiropoulos P,
Roche S, Ringe J, Lehmann S, Kritikos H, Vlahava VM, Delorme B, Eliopoulos GD, Jorgensen C, Charbord P, Hupl T, Boumpas DT, Papadaki HA: Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis.

Ann Rheum Dis 2008, 67:741-749. PubMedAbstract | PublisherFullText

Guiducci S, Manetti M, Romano E, Mazzanti B, Ceccarelli C, Dal Pozzo S, Milia AF, Bellando-Randone S, Fiori G, Conforti ML, Saccardi R, Ibba-Manneschi L, Matucci-Cerinic M: Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.

Ann Rheum Dis 2011, 70:2011-2021. PubMedAbstract | PublisherFullText

Subramanian A, Shu-Uin G, Kae-Siang N, Gauthaman K, Biswas A, Choolani M, Bongso A, Chui-Yee F: Human umbilical cord Whartons jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells.

J Cell Biochem 2012, 113:1886-1895. PubMedAbstract | PublisherFullText

Secco M, Moreira YB, Zucconi E, Vieira NM, Jazedje T, Muotri AR, Okamoto OK, Verjovski-Almeida S, Zatz M: Gene expression profile of mesenchymal stem cells from paired umbilical cord units: cord is different from blood.

Stem Cell Rev 2009, 5:387-401. PubMedAbstract | PublisherFullText | PubMedCentralFullText

Kim MJ, Shin KS, Jeon JH, Lee DR, Shim SH, Kim JK, Cha DH, Yoon TK, Kim GJ: Human chorionic-plate-derived mesenchymal stem cells and Whartons jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.

Cell Tissue Res 2011, 346:53-64. PubMedAbstract | PublisherFullText

See more here:
Umbilical cord mesenchymal stem cell transplantation in ...